Astatine-211 Production at Texas A&M University
ORAL
Abstract
In the past few years, TAMU has developed the capacity to produce, isolate, and ship astatine-211 for eventual preclinical studies of targeted alpha therapy for cancer treatment. This progress has involved beam development, radiation detection, and chemistry innovations for extraction and successful shipment. The necessary infrastructure, recent successes, and future directions for isotope production at TAMU will be discussed.
*This work is supported by the U.S. Department of Energy Isotope Program, managed by the Office of Science for Isotope R&D and Production under Award No. DE-SC002095, as well as infrastructure supported by U.S. Department of Energy under Award No. DE-FG02-93ER4077.
–
Presenters
-
Sherry J Yennello
- Texas A&M